SCHEMBL947192

SCHEMBL947192

CCc1nc(C)n2c1C(=O)N(C1CCN(C(=O)OC(C)(C)C)CC1)CC2

nearest known ligand 0.51

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.51
GPR119 Q8TDV5 7/20 0.39
DPP4 P27487 1/20 0.39
EED O75530 1/20 0.38
RBBP4 Q09028 1/20 0.38
SUZ12 Q15022 1/20 0.38
EZH2 Q15910 1/20 0.38
AEBP2 Q6ZN18 1/20 0.38
FPR2 P25090 1/20 0.38
USP30 Q70CQ3 1/20 0.37
MAPT P10636 2/20 0.37
KDM4E B2RXH2 1/20 0.37
THRB P10828 1/20 0.37
CTSD P07339 1/20 0.37
CTSE P14091 1/20 0.37
BACE1 P56817 1/20 0.37
HPGD P15428 1/20 0.36
HCAR1 Q9BXC0 1/20 0.36
BCDIN3D Q7Z5W3 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL948071 0.79 TP53 (0.51) TP53GPR119DPP4FPR2MAPT
SCHEMBL947847 0.75 TP53 (0.53) TP53GPR119FPR2MAPTKDM4E
SCHEMBL947679 0.73 TP53 (0.53) TP53GPR119FPR2USP30MAPT
SCHEMBL16616327 0.71 TP53 (0.43) TP53GPR119EEDRBBP4SUZ12
SCHEMBL27189242 0.69 TP53 (0.59) TP53GPR119DPP4FPR2USP30
SCHEMBL22720469 0.69 TP53 (0.53) TP53GPR119FPR2MAPTKDM4E
SCHEMBL17978936 0.69 TP53 (0.50) TP53GPR119DPP4FPR2MAPT
SCHEMBL14651344 0.68 TP53 (0.52) TP53GPR119DPP4FPR2USP30
SCHEMBL950313 0.68 F10 (0.47) TP53GPR119FPR2USP30MAPT
SCHEMBL8667894 0.68 TP53 (0.52) TP53GPR119FPR2MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2011-01-13 US disclosed
US-20070004736-A1 Imidazole derivative, process for producing the same, and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2007-01-04 US disclosed
EP-1564213-A1 IMIDAZOLE DERIVATIVE, PROCESS FOR PRODUCING THE SAME, AND USE Takeda Pharmaceutical Company Limited (JP) 2005-08-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004736-A1 Imidazole derivative, process for producing the same, and use HRH4, F2, HRH2 TP53 4661/4885GPR119 1327/4885DPP4 4579/4885
US-20110009389-A1 IMIDAZOLE DERIVATIVE, THEIR PRODUCTION AND USE F2, H1-3, CYC1 TP53 4591/4885GPR119 1118/4885DPP4 4756/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.